Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 1998, p. 2521-2526, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Interaction of Streptococcus pneumoniae and
Moraxella catarrhalis: Investigation of the Indirect
Pathogenic Role of
-Lactamase-Producing Moraxellae by Use of a
Continuous-Culture Biofilm System
R. K.
Budhani and
J. K.
Struthers*
Department of Medical Microbiology,
Manchester Royal Infirmary and the University of Manchester,
Manchester M13 9WL, United Kingdom
Received 19 December 1997/Returned for modification 1 April
1998/Accepted 13 July 1998
 |
ABSTRACT |
The majority of clinical isolates of Moraxella
catarrhalis produce
-lactamase. The role of this
enzyme in the phenomenon of indirect pathogenicity, in which a true
pathogen such as Streptococcus pneumoniae is protected from
the action of certain
-lactam antibiotics, is well recognized. By
using a simple continuous-culture biofilm system, it has been shown
that the pneumococcus attains high titers in excess of 1012
CFU/biofilm; furthermore, the penicillin-sensitive pneumococcus used
remained susceptible to a range of
-lactam antibiotics in these
biofilms (R. K. Budhani and J. K. Struthers, J. Antimicrob. Chemother. 40:601-602, 1997). This system was used to characterize the
antibiotic susceptibility of this isolate when grown with
-lactamase-negative or -positive moraxellae. When grown with
-lactamase-producing moraxellae in the presence of either
benzylpenicillin or amoxicillin, the pneumococcus was protected in
the range of the antibiotic concentrations to which it would be
considered resistant. With amoxicillin-clavulanic acid the titers of
the two organisms collapsed at the antibiotic concentration at
which moraxellae became susceptible. The levels of
-lactamase activity in cell-free supernatants of
broth culture, in biofilm, and in biofilm effluent revealed distinct
differences in this activity; levels in biofilm were
significantly lower than those in broth culture supernatants. The
system appears suitable for studying organisms under
antibiotic stress and for investigating the interactions of bacteria
under such conditions.
 |
INTRODUCTION |
Moraxella catarrhalis is
a gram-negative diplococcus which is often isolated from respiratory
tract secretions sent to microbiology laboratories; a survey conducted
in the United Kingdom in 1991 showed that M. catarrhalis was the third most common organism isolated after Streptococcus pneumoniae and
Haemophilus influenzae (16). An important feature
of M. catarrhalis is that at least 90% of isolates produce
a
-lactamase with activity against
-lactams such as
penicillin and the amino penicillins (7). Based on isoelectric focusing patterns, the
-lactamases of M. catarrhalis can be designated as BRO-1 or BRO-2. The former
type is more common, and levels of expression of the BRO-1 enzyme are
higher than those of BRO-2 (5, 7). While the self-protective
role of the enzyme is evident, the phenomenon of indirect pathogenicity
in mixed infections, in which a true pathogen such as a pneumococcus is also protected by the enzyme, is well recognized (1,
18). It is known that the sputa of patients being treated with
penicillin, from which both pneumococci and
-lactamase-producing moraxellae have been isolated, do
not contain detectable amounts of the antibiotic (18). This
protective effect has been recently demonstrated in vivo, with a mouse
model (10), but the details of this interaction in vitro
have not been clearly defined. Kassim and Williams used broth cultures
in their investigations and have demonstrated a degree of protection of
pneumococci by
-lactamase-positive moraxellae in the
presence of antibiotics such as penicillin (12, 13). This
system was limited by the fact that it does not involve a continuous
culture and thus variations in the growth rates of the organisms can
occur.
A more reproducible and continuous culture system would be important in
defining the relationship between S. pneumoniae and M. catarrhalis. The simple Sorbarod continuous-culture
biofilm system appears ideal for such an investigation. We have
shown recently that S. pneumoniae attains consistently high
concentrations (>1012 CFU/biofilm) for a period of
at least 96 h in Sorbarod filters (2); these
filters consist of a concertina of cellulose fibers in a paper sleeve.
Here we characterize the growth of pneumococci on these biofilms in the
presence of
-lactamase-positive or
-lactamase-negative moraxellae and of different
concentrations of three
-lactam antibiotics. The
characteristics of the protective effect of moraxella BRO-1
-lactamase in a biofilm system are described.
 |
MATERIALS AND METHODS |
Bacteria.
S. pneumoniae ATCC 671310 and the
clinical isolate (serotype 19) described previously were used
(2). M. catarrhalis ATCC 25238 (
-lactamase negative),
-lactamase-positive
M. catarrhalis (BRO-1
-lactamase), and
penicillin-intermediate isolates of S. pneumoniae were
obtained from departmental teaching stocks. Isolates of S. pneumoniae resistant to penicillin were obtained from the Antibiotic Reference Laboratory, Public Health Laboratory Service, Colindale, United Kingdom.
Antibiotics.
The following antibiotics were used:
benzylpenicillin (Britannia, Redhill, United Kingdom), amoxicillin and
amoxicillin-clavulanic acid (SmithKline Beecham, Worthing, United
Kingdom), vancomycin (Lilly, Basingstoke, United Kingdom), and
aztreonam (Bristol-Myers Squibb, Hounslow, United Kingdom). The ratio
of amoxicillin to clavulanic acid used was 5:1.
Tube MIC and MBC and the E test.
Tube MIC and
minimal-bactericidal-concentration (MBC) tests were done by a
recognized procedure using brain heart infusion (BHI) broth (Oxoid,
Unipath, Basingstoke, United Kingdom); the concentration of bacteria at
the beginning of each experiment was approximately 105
CFU/ml (11). The penicillin E test was performed with direct sensitivity test agar (Oxoid, Unipath), according to the
manufacturer's instructions (AB Biodisk, Solna, Sweden).
Sorbarod biofilms.
The method described previously was used
(2, 9, 14). For each experiment, 12 20- by 10-mm Sorbarod
filters (Ilacon, Tonbridge, Kent, United Kingdom) were prepared in
order to have a control antibiotic-free biofilm and enough biofilms to
cover twofold dilutions of an antibiotic in concentrations ranging from 0.004 to 16 mg/liter. Individual filters were inoculated with 3 ml of
an exponential-phase broth culture of an organism or with the same
volume of both bacteria. For broth culture and the biofilm "feeding," BHI was used. BHI was delivered at a rate of 0.1 ml/min by means of a 12-channel 205U peristaltic pump (Watson Marlow, Falmouth, United Kingdom). After 24 h, when steady-state growth had been obtained (2), individual biofilms were exposed to a
single concentration of an antibiotic for 18 h, using the same broth (BHI) and flow rate. After this period, effluent was collected for 15 min in order to determine the concentration of planktonic bacteria, and the biofilm was then disintegrated in 5 ml of BHI broth
with a vortex mixer and the titers of the bacteria were determined by a
recognized method (11). All biofilm titers were multiplied
by a factor of 6.57 to take into account the 5 ml of broth added and
the volume of the filter itself (14). The titers of effluent
and biofilm were determined in triplicate on Columbia blood agar
(Oxoid). When titrating mixtures of the two organisms, Columbia blood
agar containing 2 µg of vancomycin per ml or 10 µg of aztreonam per
ml was used as the selective medium for M. catarrhalis or
S. pneumoniae, respectively. The biofilm eradicating concentration (BEC), the lowest concentration of an antibiotic that
eradicated the organisms from biofilm, was determined as described
previously (2, 14).
In order to ensure that bacteria were not being killed by any
-lactam antibiotics during vortex mixing of the biofilm and the
titration steps, a broad-spectrum
-lactamase preparation (Bacillus cereus
-lactamases I and II; Oxoid) was
included at these stages in several experiments. The final
concentration of the added
-lactamase was approximately
104 mU/ml.
Determination of moraxella
-lactamase activity.
The method used was essentially the same as that described previously
(3, 12). Supernatants of broth culture, biofilm after vortex
mixing, and biofilm effluent were collected following centrifugation at
2,000 × g for 10 min. One-hundred-microliter volumes of
the supernatant were mixed with equal volumes of nitrocefin (Oxoid), at
a concentration of 100 µg/ml, in the wells of 96-well microtiter
plates (Sterilin, Stone, Staffordshire, United Kingdom). Plates were
incubated in the dark at 37°C for 30 min and were then read
immediately at 492 nm in a Multiscan MCC/340 MKII plate reader.
Readings were converted to milliunits per milliliter by using a
standard curve prepared under the same conditions with B. cereus type I
-lactamase (Sigma, Poole, Dorset, United
Kingdom) of known specific activity. Readings were converted to
nanomoles of nitrocefin hydrolyzed per minute.
 |
RESULTS |
The results of the tube MIC and MBC tests, E test, and BEC
test for the various isolates of S. pneumoniae are shown in
Table 1. Using the tube MIC and MBC test
and E test as controls, it is evident that the BECs of the various
penicillin-sensitive, -intermediate, and -resistant isolates of
pneumococcus tested showed that irrespective of penicillin
susceptibility, there was no protection of the organism in this
biofilm mode of growth. We were therefore confident that any survival
of the pneumococcal isolate serotype 19 in the presence of antibiotic
would be due to M. catarrhalis BRO-1
-lactamase.
In order to determine if the initial biofilm inoculum concentrations
had any effect on the ability of the two organisms to establish
themselves together on a biofilm, the following experiment was done.
Undiluted broth cultures of either S. pneumoniae or M. catarrhalis were mixed with a 10-fold dilution of the other organism; this mixture was used to inoculate a Sorbarod filter. After
24 h, effluent was collected, the biofilm was sacrificed, and the
titers of the two organisms were determined on the selective media. The
results in Table 2 show that after the
24-h period, the two organisms achieved similar titers within the
biofilms, on the order of 1013 CFU/biofilm. Fluctuations in
the titers of the organisms in the biofilm effluent were noted; on
occasion, they were in excess of 10-fold, as shown in Table 2. It is
important to note that the effluent titers were at least 4 log values
lower than those in the biofilms.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Biofilm and effluent organism titers in mixed Sorbarod
biofilm cultures of S. pneumoniae serotype 19 and
M. catarrhalis ATCC 25238
|
|
The results of the experiments combining the pneumococcus with either
-lactamase-negative or -positive M. catarrhalis
in the presence of various concentrations of antibiotics are shown in
Fig. 1. Clearly, the
-lactamase-negative moraxella was unable to protect the
pneumococcus; the BEC obtained for the antibiotics used with serotype
19 was essentially the same as that shown in Table 1. In contrast, the
presence of
-lactamase-positive moraxellae had a definite
protective effect. In repeated experiments with benzylpenicillin and
amoxicillin, there was an approximate 3- to 4-log value collapse of the
pneumococcal titer at concentrations between 0.064 and 2.0 mg/liter.
The surviving pneumococcal population, on the order of 1010
CFU/biofilm, was protected at concentrations of both penicillin and
amoxicillin of above 2 mg/liter. With amoxicillin-clavulanic acid, the
titer of the pneumococcus was essentially maintained until the collapse
of the moraxella population at 1 to 2 mg/liter; in these experiments,
the pneumococcal population was then eliminated. Despite the massive
collapse in the moraxella population in the presence of
amoxicillin-clavulanic acid, a surviving population of this organism,
with a biofilm titer in the region of 107 CFU/filter,
was maintained up to at least 16 mg/liter (data not shown). The results
of the pneumococcal experiments with benzylpenicillin and amoxicillin
in which B. cereus
-lactamase was included
in biofilm vortex mixing and in all the subsequent
titration steps are shown in Tables 3 and
4. These results show that the addition of the B. cereus
-lactamase did not
significantly affect the titers.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Biofilm and effluent titers of S. pneumoniae
( and , respectively) and M. catarrhalis ( and ,
respectively) ( -lactamase negative [a, c, and e] and
-lactamase positive [BRO1] [b, d, and f]) grown together
on Sorbarod biofilms in the presence of benzylpenicillin (a and b),
amoxicillin (c and d), and amoxicillin-clavulanic acid (e and f).
Individual filters were inoculated with mixtures of the two organisms
and, after 24 h, were exposed to a single concentration of the
antibiotic for 18 h. Effluent was collected for 15 min, the
biofilm was sacrificed, and the titers of pneumococci and moraxellae
were determined on selective agar. Titers in biofilm are expressed as
total recoverable CFU per biofilm. Titers in effluent are expressed as
CFU per milliliter.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Pneumococcal titers from biofilms and biofilm effluents
after vortex mixing and subsequent titration in the presence and
absence of
B. cereus -lactamasea
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Pneumococcal titers from biofilms and biofilm effluents
after vortex mixing and subsequent titration in the presence and
absence of
B. cereus -lactamasea
|
|
The
-lactamase activities in biofilm and effluent
supernatants are shown in Fig. 2. For
penicillin there was a random level of
-lactamase activity,
but for both amoxicillin and amoxicillin-clavulanic acid an increase in
the biofilm
-lactamase activity was noted at antibiotic
concentrations between 0.125 and 8 mg/liter. This increase was matched
to a lesser extent in the biofilm effluents. An increase in
cell-free
-lactamase activity was also observed, for
example, when moraxella strain BRO1 alone was exposed to amoxicillin under the same biofilm conditions (data not shown). It was considered important to determine the level of cell-free
-lactamase
activity during the growth of strain BRO1 in broth culture and
during the establishment of the organism on biofilms, in order to
determine the relative degree of
-lactamase activity under
the two different growth conditions. The results in Fig.
3 show that
-lactamase activity was always lower in the biofilms. Even at the very high organism numbers achieved in biofilm after 24 h, the rate of
activity was always lower than that of the broth culture cell-free
fraction.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
-Lactamase activities in the supernatant fractions of
biofilm ( ) and effluent ( ) preparations (Fig. 1) with the
mixtures of the pneumococcus and strain BRO1. The supernatant was
obtained by centrifuging both biofilms after vortex mixing and effluent
at 3,500 rpm for 10 min. -Lactamase activity (expressed as nanomoles
of nitrocefin hydrolyzed per minute) was determined as described in the
text. (a, benzylpenicillin; b, amoxicillin; c, amoxicillin-clavulanic
acid).
|
|

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
(a) Titers of strain BRO1 grown in broth culture and
biofilm (plus biofilm effluent) collected at various times after
inoculation. Titers in biofilm are expressed as recoverable CFU per
biofilm; titers in effluent are expressed as CFU per milliliter. (b)
-Lactamase activity (nanomoles of nitrocefin hydrolyzed per minute)
in the supernatants of the same specimens. , broth; , biofilm;
, effluent.
|
|
 |
DISCUSSION |
The work presented here shows that the Sorbarod continuous-culture
biofilm system is useful for studying the effect of antibiotics on
organisms grown together. By defining the system with strains of
pneumococcus with different susceptibilities to penicillin we were able
to show that this biofilm mode of growth did not provide any protection
for this organism. This is in contrast to the results of previous
studies, on the basis of which the biofilm mode of growth has been
considered protective for microorganisms (4, 8, 15). When
the two bacteria were grown together on a biofilm, in the absence of
antibiotics, they reached and maintained the same titers as the
organisms grown separately, that is, in excess of 1012
CFU/biofilm. We were therefore confident that in the absence of
antibiotics, neither organism could establish and maintain itself on
biofilm to the detriment of the other. The BEC for the pneumococcus in
the presence of the
-lactamase-negative moraxella was the
same as that published previously (2). When the pneumococcus was grown with the
-lactamase-positive moraxella in the
presence of benzylpenicillin or amoxicillin, an approximately 4-log
value collapse of the pneumococcus population was observed. The
surviving pneumococcal population, on the order of 1010
CFU/biofilm, was protected in the antibiotic concentration at which the
organism is considered to be highly resistant to penicillin, that is,
in excess of 2 mg/liter (6). With amoxicillin-clavulanic acid the protective effect existed up to the collapse of the moraxella population at concentrations of 1 to 2 mg/liter and above, showing the
positive effect of clavulanic acid in abolishing the indirect pathogenic effect of
-lactamase-producing M. catarrhalis; however, the pneumococcus would still be regarded as
resistant according to the criteria used (6). Thus, there
appeared to be two identifiable pneumococcal populations observed in
the experiments with penicillin and amoxicillin, one in the sensitive
to intermediate range and another that remained resistant to these
antibiotics due to the protective effect of the moraxella
-lactamase.
The
-lactamase levels in biofilm and effluent supernatants
(Fig. 2) showed that there was no discernible difference across the
range of penicillin concentrations used. However, peaks were noted in
the biofilm supernatants in the amoxicillin and
amoxicillin-clavulanic acid experiments; a rise in
-lactamase activity in the effluents was less distinct. This
rise in the cell-free
-lactamase activity in biofilm
may represent a subpopulation of strain BRO1 that undergoes lysis
as a result of antibiotic activity, releasing the enzyme into the
cell-free environment. Similar results were obtained with strain
BRO1 alone when it was exposed to amoxicillin under the same biofilm
conditions (data not shown). Figure 3 shows the titers of bacteria and
-lactamase levels in cell-free supernatants both of broth
culture and during the establishment of strain BRO1 on biofilms.
Despite the significantly higher bacterial titer in biofilm than in
broth, the level of enzyme activity in biofilm supernatants was always
lower. Comparing the maximum broth titer at 18 h with the maximum
biofilm titer at 48 h and the enzyme activities at these times
showed that the relative activity of cell-free enzyme in biofilm was on
the order of 200-fold lower (Fig. 3). The population of moraxellae
collected over 15 min in the effluent must reflect the presence of free
planktonic bacteria which are eluted from the biofilm. As shown in Fig.
3, this effluent population is at least 3 log values less than the
equivalent established biofilm population of the moraxella. Examining
the levels of cell-free enzyme activity in the established biofilm and
effluent populations showed that, based on relative organism numbers,
the activity in biofilm is at least 3 to 4 log values lower than that
in the effluent. Production of
-lactamase by
M. catarrhalis is considered to be constitutive
(17); however, some regulatory system may exist at the
high organism numbers achieved in this biofilm system.
Of particular interest in this study was the absence of strain BRO1
bacteria in certain effluents of mixtures of the two organisms. While
this was seen on occasion when the pneumococcus and the moraxella were
grown on Sorbarod filters in the absence of antibiotics, this
phenomenon was regularly observed in mixed infections in the presence
of lower concentrations of the three antibiotics used. This is evident
in the graphs presented in Fig. 1, which show that the moraxella was
absent from 13 of 15 effluents at antibiotic concentrations below 0.25 mg/liter. This phenomenon was observed in repeated experiments with
penicillin (two of three experiments), amoxicillin (two of three
experiments), and amoxicillin-clavulanic acid (two of two experiments).
The effluent curves of strain BRO1 in Fig. 1 show that when it is
present, titers were on the order of 106 to 108
CFU/ml, at least 4 log values lower than the titer of the equivalent biofilm population at a particular antibiotic concentration. Despite this significant difference in the biofilm and effluent moraxella titers, the repeated absence of the
-lactamase-positive
moraxella could indicate a type of interspecies signalling system
whereby a pneumococcus population stressed by an antibiotic attempts to keep an ally in the biofilm environment itself. The indirect pathogenic role of
-lactamase-producing M. catarrhalis that
has been proposed (1, 18) may not therefore involve a
passive interaction. The Sorbarod biofilm system thus appears to have a
role in elucidating the interaction between bacteria when they
are exposed to antibiotics.
 |
ACKNOWLEDGMENTS |
R. K. Budhani is a predoctoral student funded by a
scholarship from the Shah Latif University, Khairpur, Pakistan.
We thank A. Johnson of the Public Health Laboratory Service for
providing the resistant pneumococcal isolates.
 |
FOOTNOTES |
*
Corresponding author. Present address: Public Health
Laboratory Service, Coventry and Warwickshire Hospital, Stoney Stanton Rd., Coventry, CV1 4FH, United Kingdom. Phone: 44(1203) 844122. Fax:
44(1203)220081. E-mail:
jkstruthers{at}covphl.globalnet.co.uk.
 |
REFERENCES |
| 1.
|
Brook, I.
1989.
The concept of indirect pathogenicity by -lactamase production, especially in ear, nose and throat infection.
J. Antimicrob. Chemother.
24:63-72[Abstract/Free Full Text].
|
| 2.
|
Budhani, R. K., and J. K. Struthers.
1997.
The use of Sorbarod biofilms to determine the antimicrobial susceptibilities of a strain of Streptococcus pneumoniae.
J. Antimicrob. Chemother.
40:601-602[Free Full Text].
|
| 3.
|
Dragicevic, P.,
S. L. Hill,
D. Burnett,
D. Merrikin, and R. A. Stockley.
1989.
Activities and sources of -lactamase in sputum from patients with bronchiectasis.
J. Clin. Microbiol.
27:1055-1061[Abstract/Free Full Text].
|
| 4.
|
Duguid, I. G.,
E. Evans,
M. R. W. Brown, and P. Gilbert.
1992.
Effect of biofilm culture on the susceptibility of Staphylococcus epidermidis to tobramycin.
J. Antimicrob. Chemother.
30:803-810[Abstract/Free Full Text].
|
| 5.
|
Farmer, T., and C. Reading.
1982.
-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.
Antimicrob. Agents Chemother.
21:506-508[Abstract/Free Full Text].
|
| 6.
|
Friedland, I. R., and G. H. McCracken.
1994.
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
N. Engl. J. Med.
331:377-382[Free Full Text].
|
| 7.
|
Fung, C. P.,
S. F. Yeo, and D. M. Livermore.
1994.
Susceptibility of Moraxella catarrhalis isolates to -lactam antibiotics in relation to -lactamase pattern.
J. Antimicrob. Chemother.
33:215-222[Abstract/Free Full Text].
|
| 8.
|
Gander, S.
1996.
Bacterial biofilms: resistance to antimicrobial agents.
J. Antimicrob. Chemother.
37:1047-1050[Free Full Text].
|
| 9.
|
Hodgson, A. E.,
S. M. Nelson,
M. R. W. Brown, and P. Gilbert.
1995.
A simple in-vitro model for growth control of bacterial biofilms.
J. Appl. Bacteriol.
79:87-93[Medline].
|
| 10.
|
Hol, H.,
E. E. M. van Dijke,
C. M. Verduin,
J. Verhoef, and H. van Dijk.
1994.
Experimental evidence for Moraxella-induced neutralisation in pneumococcal pneumonia.
J. Infect. Dis.
170:1613-1616[Medline].
|
| 11.
|
Holt, A., and D. Brown.
1989.
Antimicrobial susceptibility testing, p. 167-194.
In
P. M. Hawkey, and D. A. Lewis (ed.), Medical bacteriology, a practical approach. IRL Press, Oxford, United Kingdom.
|
| 12.
|
Kassim, M.
1994.
The in-vitro studies of Branhamella catarrhalis BRO1: epidemiology and antimicrobial susceptibilities with emphasis on the importance of the -lactamase enzyme. Ph.D. thesis.
Queen Mary's College, University of London, London, United Kingdom.
|
| 13.
|
Kassim, M., and J. D. Williams.
1992.
In-vitro studies of the indirect pathogenic role of Branhamella (Moraxella) catarrhalis BRO1, abstr. 5.
In
Forum of Evaluation of Anti-Infective Therapy, Antibiotics and the Respiratory Tract.
|
| 14.
|
Muli, F., and J. K. Struthers.
1998.
Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus.
Antimicrob. Agents Chemother.
42:1428-1432[Abstract/Free Full Text].
|
| 15.
|
Nichols, W. W.
1991.
Biofilms, antibiotics and penetration.
Rev. Med. Microbiol.
2:177-181.
|
| 16.
|
Powell, M.,
D. Mcvey,
M. H. Kassim,
H. Y. Chen, and J. D. Williams.
1991.
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the United Kingdom from sputa.
J. Antimicrob. Chemother.
28:249-259[Abstract/Free Full Text].
|
| 17.
|
Stobberingh, E. E.,
H. J. Van Eck,
A. W. Houben, and C. P. A. Van Boven.
1986.
Analysis of the relationship between ampicillin resistance and -lactamase production in Branhamella catarrhalis.
Drugs
31:23-27.
|
| 18.
|
Wardle, J. R.
1986.
Branhamella catarrhalis as an indirect pathogen.
Drugs
31:93-96.
|
Antimicrobial Agents and Chemotherapy, October 1998, p. 2521-2526, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
de Vries, S. P. W., Bootsma, H. J., Hays, J. P., Hermans, P. W. M.
(2009). Molecular Aspects of Moraxella catarrhalis Pathogenesis. Microbiol. Mol. Biol. Rev.
73: 389-406
[Abstract]
[Full Text]
-
O'Dwyer, C. A., Li, M.-S., Langford, P. R., Kroll, J. S.
(2009). Meningococcal biofilm growth on an abiotic surface - a model for epithelial colonization?. Microbiology
155: 1940-1952
[Abstract]
[Full Text]
-
Wang, W., Richardson, A. R., Martens-Habbena, W., Stahl, D. A., Fang, F. C., Hansen, E. J.
(2008). Identification of a Repressor of a Truncated Denitrification Pathway in Moraxella catarrhalis. J. Bacteriol.
190: 7762-7772
[Abstract]
[Full Text]
-
Wang, W., Reitzer, L., Rasko, D. A., Pearson, M. M., Blick, R. J., Laurence, C., Hansen, E. J.
(2007). Metabolic Analysis of Moraxella catarrhalis and the Effect of Selected In Vitro Growth Conditions on Global Gene Expression. Infect. Immun.
75: 4959-4971
[Abstract]
[Full Text]
-
Pearson, M. M., Hansen, E. J.
(2007). Identification of Gene Products Involved in Biofilm Production by Moraxella catarrhalis ETSU-9 In Vitro. Infect. Immun.
75: 4316-4325
[Abstract]
[Full Text]
-
O'Connell, H. A., Kottkamp, G. S., Eppelbaum, J. L., Stubblefield, B. A., Gilbert, S. E., Gilbert, E. S.
(2006). Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm.. Appl. Environ. Microbiol.
72: 5013-5019
[Abstract]
[Full Text]
-
Pearson, M. M., Laurence, C. A., Guinn, S. E., Hansen, E. J.
(2006). Biofilm Formation by Moraxella catarrhalis In Vitro: Roles of the UspA1 Adhesin and the Hag Hemagglutinin. Infect. Immun.
74: 1588-1596
[Abstract]
[Full Text]
-
Oldak, E., Trafny, E. A.
(2005). Secretion of Proteases by Pseudomonas aeruginosa Biofilms Exposed to Ciprofloxacin. Antimicrob. Agents Chemother.
49: 3281-3288
[Abstract]
[Full Text]
-
Lafontaine, E. R., Wall, D., Vanlerberg, S. L., Donabedian, H., Sledjeski, D. D.
(2004). Moraxella catarrhalis Coaggregates with Streptococcus pyogenes and Modulates Interactions of S. pyogenes with Human Epithelial Cells. Infect. Immun.
72: 6689-6693
[Abstract]
[Full Text]
-
Conley, J., Olson, M. E., Cook, L. S., Ceri, H., Phan, V., Davies, H. D.
(2003). Biofilm Formation by Group A Streptococci: Is There a Relationship with Treatment Failure?. J. Clin. Microbiol.
41: 4043-4048
[Abstract]
[Full Text]
-
Pearson, M. M., Lafontaine, E. R., Wagner, N. J., St. Geme III, J. W., Hansen, E. J.
(2002). A hag Mutant of Moraxella catarrhalis Strain O35E Is Deficient in Hemagglutination, Autoagglutination, and Immunoglobulin D-Binding Activities. Infect. Immun.
70: 4523-4533
[Abstract]
[Full Text]
-
Verduin, C. M., Hol, C., Fleer, A., van Dijk, H., van Belkum, A.
(2002). Moraxella catarrhalis: from Emerging to Established Pathogen. Clin. Microbiol. Rev.
15: 125-144
[Abstract]
[Full Text]